Status
Conditions
About
The study is to determine the long-term outcome of patients with coronary triple vessels disease (TVD) in the real world of China, by three different treatment strategies: percutaneous coronary intervention (PCI), Coronary artery bypass graft (CABG) or optimal medication therapy (OMT).
Full description
About 10,000 participants will be enrolled into this retrospective study. Study coordinators will include both men and women over the age of 18 who had angiographic proved triple-vessel disease in a 15 years long-term. Detailed procedural data will be obtained by the study coordinator and local principal investigator. These data will be entered into the electronic data capture system. Participants will have telephone follow-up interviews conducted by the centralized follow-up center at Fuwai Hospital.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
10,000 participants in 3 patient groups
Loading...
Central trial contact
Lei Song, MD; Lei Song, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal